


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
-17.00%
+8.87%
+2.92%
VRTX
Vertex Pharma
$468.41
Strengths

Earnings are forecast to grow

Upgraded on attractively valued

Outperform the market

Expands stock buyback program
Risk Analysis

Investors losing their confidence
VRTX Price Performance
$462.9 (+1.19%)
$417.21 (+12.27%)
$401 (+16.81%)
$469.97 (-0.33%)
VRTX overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Above analyst estimates

Reported a strong earnings
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Price value has negative momentum
Activity
Activity

Investors losing their confidence

Expands stock buyback program
Future
Future

Earnings are forecast to grow

Outperform the market
![]()
VRTX Analysts opinion is positive and also has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
VRTX Street Sentiment is bullish and have positive views on the near-term outlook
VRTX has Low risk level based on volatility, sector strength, volume, investor confidence and outlook.
Click here to check what is your level of risk
Risks Indicators

Investors losing confidence

Average key support and resistance price levels
What is VRTX current stock price?
What are VRTX stock strengths?
What is VRTX Risk Level?
What is VRTX market cap and volume?
What is VRTX current Stock IQ?
Should I buy VRTX stock right now?
Is VRTX a Strong Buy right now?
What does a 'Strong Buy' rating mean for VRTX?
What does a 'Strong Sell' rating mean for VRTX?
What factors influence VRTX's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
-17.00%
+8.87%
+2.92%
VRTX
Vertex Pharma
Current Price
$468.41
Stock Insights
Strengths

Earnings are forecast to grow

Upgraded on attractively valued

Outperform the market

Expands stock buyback program
Risk Analysis

Investors losing their confidence

VRTX Price Performance
$462.9 (+1.19%)
$417.21 (+12.27%)
$401 (+16.81%)
$469.97 (-0.33%)
VRTX Analysts Opinion
VRTX Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Above analyst estimates

Reported a strong earnings
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Price value has negative momentum
Activity
Activity

Investors losing their confidence

Expands stock buyback program
Future
Future

Earnings are forecast to grow

Outperform the market
![]()
VRTX Analysts opinion is positive and also has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
VRTX Street Sentiment is bullish and have positive views on the near-term outlook
VRTX has Low risk level based on volatility, sector strength, volume, investor confidence and outlook.
Click here to check what is your level of risk
Risks Indicators

Investors losing confidence

Average key support and resistance price levels
Jan 06, 2026
Upgrade
Outperform
Wolfe Research
Nov 26, 2025
Initiate
Buy
Scotiabank
Nov 08, 2025
Reiterate
Buy
UBS
Nov 06, 2025
Reiterate
Buy
Goldman Sachs
Nov 05, 2025
Reiterate
Hold
Stifel
Nov 05, 2025
Reiterate
Hold
Stifel
Nov 05, 2025
Reiterate
Overweight
Piper Sandler
Nov 05, 2025
Reiterate
Neutral
DA Davidson
Nov 05, 2025
Reiterate
Outperform
Citizens
VRTX Stock IQ
VRTX Latest Analysis
Wall Street Analysts Think Vertex (VRTX) Is a Good Investment: Is It?. According to the average brokerage recommendation (ABR) one should invest in Vertex (VRTX). It is debatable whether this highly sought-after metric is effective because Wall Street analysts recommendations tend to be overly optimistic. Would it be worth investing in the stock?
Today
Kimberly Clark S&P Global Exxon Mobil And A Health Care Stock On CNBCs Final Trades. On CNBC'.s “.Halftime Report Final Trades”. ) has nice little chart here over the last few months up around 30% and expects it to continue.Lending support to his choice RBC Capital analyst Brian Abrahams on Thursday upgraded Vertex Pharmaceuticals from Sector Perform to Outperform and raised the price target from $455 to $546.
Today
RBC Capital Upgrades Vertex Pharmaceuticals (VRTX). Fintel reports that on January 22 2026 RBC Capital upgraded their outlook for Vertex Pharmaceuticals (NasdaqGS:VRTX) from Sector Perform to Outperform. Analyst Price Forecast Suggests 8.58% Upside
Today
Vertex Pharma upgraded at RBC Capital Markets citing upside in 2026.
Thu Jan 22, 2026
Vertex Pharmaceuticals (VRTX) Stock Sinks As Market Gains: Heres Why. The latest trading day saw Vertex Pharmaceuticals (VRTX) settling at $438.92 representing a -2.36% change from its previous close.
Thu Jan 15, 2026
Vertex Pharmaceuticals Breaks Below 200-Day Moving Average - Notable for VRTX. In trading on Thursday shares of Vertex Pharmaceuticals Inc. (Symbol: VRTX) crossed below their 200 day moving average of $437.70 changing hands as low as $436.69 per share. Vertex Pharmaceuticals Inc. shares are currently trading off about 2.4% on the day. The chart below
Thu Jan 15, 2026
How Is The Market Feeling About Vertex Pharmaceuticals Inc?. ) short interest as a percent of float has fallen 3.54% since its last report. According to exchange reported data there are now Short interest is the number of shares that have been sold short but have not yet been covered or closed out. is when a trader sells shares of a company they do not own with the hope that the price will ...
Mon Jan 12, 2026
Will Vertex (VRTX) Beat Estimates Again in Its Next Earnings Report?. Vertex (VRTX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Mon Jan 12, 2026
Bernstein upgrades Vertex ahead of key renal trial readouts.
Mon Jan 12, 2026
Insiders Buy the Holdings of FHLC ETF. A look at the weighted underlying holdings of the Fidelity MSCI Health Care Index ETF (Symbol: FHLC) shows an impressive 17.5% of holdings on a weighted basis have experienced insider buying within the past six months.Vertex Pharmaceuticals Inc. (Symbol: VRTX) which makes u
Mon Jan 12, 2026
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
VRTX Stock trends
VRTX Stock performance
VRTX Stock analysis
VRTX investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.